Rebiotix completes Phase 3 clinical trial enrollment
Rebiotix, a Ferring company, has completed enrollment of the pivotal Phase 3 clinical trial for RBX2660, an investigational therapy aimed at breaking the cycle of...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
Rebiotix, a Ferring company, has completed enrollment of the pivotal Phase 3 clinical trial for RBX2660, an investigational therapy aimed at breaking the cycle of...
BioXcel Therapeutics reports that its Investigational New Drug application for BXCL501, the Company’s proprietary sublingual thin-film formulation of dexmedetomidine, has received clearance from the FDA...
A renewable chemistry company co-founded by Yale scientists, P2 Science, has attracted high level investors, including fashion and beauty giant Chanel. P2 announced this week...
Bioscience Notebook: Alexion has completed its acquisition of Achillion. NanoViricides stock soars re coronavirus fears…. more
State Senator Christine Cohen and the Connecticut legislature’s Bioscience Caucus were briefed this week by a private-sector bioscience industry advocate and by the commissioner of Connecticut’s...
QCDx, a private biotech company based in Farmington, CT that has developed a breakthrough Circulating Tumor Cell (CTC) liquid biopsy from a simple blood draw,...
David Lehman, the state’s commissioner of economic and community development, said there will be a strong push to create hubs of innovation in industries such...
Connecticut Governor Ned Lamont has announced that the first proposals he is submitting to the Connecticut General Assembly during the 2020 legislative session will be a...
With the goal of identifying advanced treatment approaches for children with genetic orthopedic conditions, Shriners Hospitals for Children® and The Jackson Laboratory (JAX) have entered...
A prominent developer is proposing to build 500,000 square feet of laboratory and life-sciences incubation space in downtown New Haven. Winstanley Enterprises LLC plans a major...